The last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...

Union home minister Amit Shah confirmed that peace has been established in Kashmir, the Northeast, and Naxal-affected areas. He highlighted...

In a strategic move to streamline hospital cash flow, HealthRail is offering expedited access to accrued revenues. This initiative specific...

At the annual Vijayadashami event, Mohan Bhagwat shared important insights on the risks associated with regime-change protests. He suggeste...

Three coronary stent models from Meril Life Sciences were withdrawn from the Sri Lankan market due to performance issues. The National Medi...

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...

Union Home Secretary Govind Mohan on Saturday said India’s internal security challenges have changed, with Naxalism largely ended, insurgen...

Nirmala Sitharaman expressed optimism regarding the speedy conclusion of the India-US trade agreement during her recent interaction. She hi...

Cabinet secretariat has directed the Union health ministry to investigate safety issues related to coronary stents. These concerns were rai...

School assemblies are essential in keeping students updated on crucial happenings both nationally and globally. Recently, the Supreme Court...

Addressing the first Home Ministers' Meeting of BIMSTEC countries, Amit Shah said India follows a policy of zero tolerance towards terroris...

The Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...

Anupam Rasayan India Ltd anticipates significant growth in its pharmaceutical segment over the next three years. The company expects pharma...

Eli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...

India’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...

What is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...

Significant price differences in healthcare consumables have drawn attention, prompting calls for better consumer protection. Maharashtra's...